Systemic Lupus Erythematosus
The most likely diagnosis is systemic lupus erythematosus (C). This 53-year-old woman presents with a 6-month history of constitutional symptoms (fever, weight loss), small-joint synovitis, arthralgia, and serositis (pleuritic chest pain with pleural effusion)—a constellation that strongly suggests SLE rather than the other options.
Diagnostic Reasoning
Why SLE Is Most Likely
Pericardial and pleural involvement occurs commonly in SLE, affecting approximately 5–15% of patients with systemic autoimmune diseases who develop pericarditis, and SLE is specifically listed among the most common autoimmune causes of serositis 1
Small-joint synovitis with arthralgia is a cardinal feature of SLE, and when combined with constitutional symptoms and serositis, this pattern strongly suggests lupus 2, 3
The 6-month duration with progressive multisystem involvement (musculoskeletal, constitutional, and serosal) fits the typical presentation of SLE, where diagnosis requires evidence of involvement in at least two organ systems 3
Pleural effusion without pulmonary embolism or consolidation is characteristic of lupus pleuritis, which represents inflammatory serositis rather than infection or thromboembolism 1
Why the Other Diagnoses Are Less Likely
Infective endocarditis (A) is unlikely because:
- Heart sounds are normal—no murmur is documented 1
- Blood cultures would be expected to be mentioned if obtained, and the 6-month chronic course without hemodynamic compromise argues against active endocarditis 1
- The absence of nail-fold infarcts (which would suggest septic emboli) further reduces this probability 1
Adult-onset Still's disease (B) is less likely because:
- The classic salmon-pink evanescent rash is absent, which is present in >85% of AOSD cases and is a major diagnostic criterion 1, 4
- While AOSD can present with fever, arthralgia, and serositis, the absence of the characteristic rash, sore throat, and marked leukocytosis (not mentioned here) makes this diagnosis less probable 1, 5
- AOSD typically presents with very high ferritin levels (>5× normal) and elevated IL-18, which are key diagnostic biomarkers not mentioned in this case 1
Rheumatoid arthritis with vasculitis (D) is unlikely because:
- RA vasculitis typically occurs in long-standing, severe, seropositive RA (usually >10 years of disease) and would be expected to show nail-fold infarcts, digital ischemia, or cutaneous ulceration—none of which are present 6
- The absence of nail-fold infarcts specifically argues against vasculitis as a complicating feature 6
- The pleural effusion in RA is typically a late manifestation in established disease, not a presenting feature in a patient without prior RA diagnosis 6
Recommended Diagnostic Workup
Obtain comprehensive autoimmune serology immediately:
- Antinuclear antibody (ANA) with titer and pattern—this is the primary screening test for SLE 3
- If ANA is positive (≥1:40), proceed with anti-double-stranded DNA (anti-dsDNA) and anti-Smith antibodies, which are highly specific for SLE 3
- Complement levels (C3, C4)—low levels suggest active lupus with immune complex consumption 1
- Complete blood count to assess for cytopenias (anemia, leukopenia, thrombocytopenia), which are common in SLE 2
Assess for renal involvement:
- Urinalysis with microscopy looking for proteinuria, hematuria, or cellular casts 1, 2
- Serum creatinine and estimated glomerular filtration rate 1
Apply the American College of Rheumatology classification criteria:
- If ≥4 of 11 criteria are met, SLE can be diagnosed with 95% specificity and 85% sensitivity 2, 3
- This patient already demonstrates: (1) arthritis, (2) serositis (pleuritis), and (3) constitutional symptoms—three criteria are already evident clinically 2, 3
Critical Diagnostic Pitfall
Do not dismiss the diagnosis if ANA is negative. While rare, ANA-negative SLE exists in patients with persistent characteristic multisystem involvement, and such patients should still be evaluated with anti-dsDNA and anti-Sm antibodies 3. However, an ANA titer <1:40 makes SLE much less likely unless there is overwhelming clinical evidence 3.
Initial Management Pending Confirmation
Refer to rheumatology urgently for patients with suspected SLE and multisystem involvement, as early diagnosis and treatment reduce morbidity and mortality 2
Hydroxychloroquine is the cornerstone of SLE treatment and reduces disease flares and constitutional symptoms; it should be initiated once the diagnosis is confirmed 2
Low-dose glucocorticoids (e.g., prednisone ≤10 mg/day) can be used to treat most manifestations while awaiting rheumatology evaluation 2
Monitor for organ damage (especially renal) every 3 months during the first 2–3 years, as this is when lupus nephritis most commonly develops 1